The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients

被引：0
|
作者：
Ariza-Heredia, Ella J. [1 ]
Shah, Dimpy P. [1 ]
El Chaer, Firas [1 ]
El Haddad, Lynn [1 ]
El-Haddad, Danielle [1 ]
Prayag, Amrita [1 ]
Nesher, Lior [1 ]
Rezvani, Katy [2 ]
Shpall, Elizabeth J. [2 ]
Chemaly, Roy F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
219
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
    Prakash, Katya
    Chandorkar, Aditya
    Saharia, Kapil K.
    DIAGNOSTICS, 2021, 11 (05)
  • [32] Two types of CMV-specific memory responses in lung transplant recipients
    Zeevi, A
    Spichty, K
    Banas, R
    Morel, P
    Iacono, A
    Dauber, J
    Yousem, S
    Pham, S
    Keenan, R
    Duquesnoy, R
    Griffith, B
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 173 - 174
  • [33] CMV viremia and development of CMV-specific cytotoxic t-cells (CMV-TC) in pediatric renal transplant recipients
    Pizzo, Helen
    Shin, Bongha
    Toyoda, Mieko
    Jordan, Stanley
    Puilyanda, Dechu
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [34] CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
    Schachtner, Thomas
    Stein, Maik
    Reinke, Petra
    TRANSPLANTATION, 2017, 101 (10) : E315 - E325
  • [35] THE PRESENCE OF CMV-SPECIFIC T-CELLS IN CMV-SERONEGATIVE KIDNEY TRANSPLANT RECIPIENTS PREDICTS OUTCOME AFTER KIDNEY TRANSPLANTATION
    Schachtner, Thomas
    Stein, Maik
    Reinke, Petra
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 6 - 7
  • [36] Acquisition of CMV-specific CD8+ T cell memory during primary CMV infection in lung transplant recipients
    Pipeling, M. R.
    West, E. E.
    Osborne, C. M.
    Migueles, S. A.
    Connors, M.
    McDyer, J. F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S146 - S146
  • [37] Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia
    Moon, S. M.
    Sung, H.
    Kim, M. -N.
    Lee, S. -O.
    Choi, S. -H.
    Kim, Y. S.
    Woo, J. H.
    Kim, S. -H.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (02) : 192 - 197
  • [38] CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy
    Mena-Romo, Juan Damian
    Romero, Pilar Perez
    Martin-Gandul, Cecilia
    Gentil, Miguel Angel
    Suarez-Artacho, Gonzalo
    Lage, Ernesto
    Sanchez, Magdalena
    Cordero, Elisa
    JOURNAL OF INFECTION, 2017, 75 (04) : 336 - 345
  • [39] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
  • [40] Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
    Zhou, Wendi
    Longmate, Jeff
    Lacey, Simon F.
    Palmer, Joycelynne M.
    Gallez-Hawkins, Ghislaine
    Thao, Lia
    Spielberger, Ricardo
    Nakamura, Ryotaro
    Forman, Stephen J.
    Zaia, John A.
    Diamond, Don J.
    BLOOD, 2009, 113 (25) : 6465 - 6476
12345